Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Angel Xinliu Li"'
Autor:
Christopher Kandel, Yaejin Lee, Maureen Taylor, Andrea Llanes, Janine McCready, Gloria Crowl, Jeff Powis, Angel Xinliu Li, Altynay Shigayeva, Lily Yip, Kevin Katz, Robert Kozak, Samira Mubareka, Allison McGeer
Publikováno v:
Journal of Infection. 85:666-670
SARS-CoV-2 shedding has changed as new variants have emerged. It is important to understand the trajectory of PCR positivity due to Omicron in vaccinated populations.Double- or triple-vaccinated adult household contacts of individuals with COVID-19 s
Autor:
Arinjay Banerjee, Jocelyne Lew, Andrea Kroeker, Kaushal Baid, Patryk Aftanas, Kuganya Nirmalarajah, Finlay Maguire, Robert Kozak, Ryan McDonald, Amanda Lang, Volker Gerdts, Sharon E. Straus, Lois Gilbert, Angel Xinliu Li, Mohammad Mozafarihasjin, Sharon Walmsley, Anne-Claude Gingras, Jeffrey L. Wrana, Tony Mazzulli, Karen Colwill, Allison J. McGeer, Samira Mubareka, Darryl Falzarano
Publikováno v:
Med (New York, N.Y.). 3(6)
The omicron variant of concern (VOC) of SARS-CoV-2 was first reported in November 2021 in Botswana and South Africa. Omicron has evolved multiple mutations within the spike protein and the receptor binding domain (RBD), raising concerns of increased
Autor:
Bhavisha Rathod, Matthew Stuible, Christine Mesa, Steven J. Drews, Angel Xinliu Li, Marc-André Langlois, Mariam Maltseva, Adrian Pasculescu, Mahya Fazel-Zarandi, Christian Gervais, Karen Colwill, François Cholette, Corey Arnold, Yannick Galipeau, Pamela J. Goodwin, Anne-Claude Gingras, Jeffrey L. Wrana, Lynda Rocheleau, Linda Bennett, Jenny Wang, Miriam Barrios-Rodiles, Mariam Iskilova, Kento T. Abe, Samira Mubareka, John Kim, Michelle A. Hladunewich, Kevin Yau, Yves Durocher, Martin Pelchat, Allison McGeer, Aimee Paterson
BACKGROUND: Testing for antibodies against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has been instrumental in detecting previous exposures and analyzing vaccine-elicited immune responses. Here, we describe a scalable "Made-in-Canad
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6f78af31ad2a992a3df7d69ae56c14be
https://doi.org/10.1101/2021.10.25.21265476
https://doi.org/10.1101/2021.10.25.21265476
Autor:
Salma Sheikh-Mohamed, Baweleta Isho, Gary Y.C. Chao, Michelle Zuo, Carmit Cohen, Yaniv Lustig, George R. Nahass, Rachel E. Salomon-Shulman, Grace Blacker, Mahya Fazel-Zarandi, Bhavisha Rathod, Karen Colwill, Alainna Jamal, Zhijie Li, Keelia Quin de Launay, Alyson Takaoka, Julia Garnham-Takaoka, Anjali Patel, Christine Fahim, Aimee Paterson, Angel Xinliu Li, Nazrana Haq, Shiva Barati, Lois Gilbert, Karen Green, Mohammad Mozafarihashjin, Philip Samaan, Patrick Budylowski, Walter L. Siqueira, Samira Mubareka, Mario Ostrowski, James M. Rini, Olga L. Rojas, Irving L. Weissman, Michal Caspi Tal, Allison McGeer, Gili Regev-Yochay, Sharon Straus, Anne-Claude Gingras, Jennifer L. Gommerman
Publikováno v:
The Journal of Immunology. 208:59.14-59.14
SARS-CoV-2 is a novel respiratory virus that has quickly spread across the globe. The virus uses a protein called Spike and its associated receptor binding domain (RBD) to interact with angiotensin converting enzyme-2 (ACE-2) on the surface of epithe